Publications by authors named "Michael D Meyer"

Claim this Profile
C
Climate research priorities for policy-makers, practitioners, and scientists in Georgia, USA.
Murray A Rudd, Althea F P Moore, Daniel Rochberg, Lisa Bianchi-Fossati, Marilyn A Brown, Michael D Meyer

Environ Manage· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New distribution and host records for Hectopsylla pulex Haller (Siphonaptera, Tungidae) with notes on biology and morphology.
Michael W Hastriter, Michael D Meyer, Richard E Sherwin, Katharina Dittmar

Zookeys· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of 2-amido-3-carboxamide thiophene CB₂ receptor agonists for pain management.
Derek W Nelson, Jennifer M Frost, Karin R Tietje, Alan S Florjancic, Keith Ryther, Michael D Meyer

Bioorg Med Chem Lett· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophore.
Michael R Schrimpf, Kevin B Sippy, Clark A Briggs, David J Anderson, Tao Li, Michael D Meyer

Bioorg Med Chem Lett· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.
Yihong Fan, Bradley A Hooker, Tiffany Runyan Garrison, Odile F El-Kouhen, Kenneth B Idler, Michael D Meyer

Eur J Pharmacol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central and peripheral sites of action for CB₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats.
Gin C Hsieh, Madhavi Pai, Prasant Chandran, Bradley A Hooker, Chang Z Zhu, Michael D Meyer

Br J Pharmacol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
John Malysz, David J Anderson, Jens H Grønlien, Jianguo Ji, William H Bunnelle, Michael D Meyer

J Pharmacol Exp Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity.
Jennifer M Frost, Michael J Dart, Karin R Tietje, Tiffany R Garrison, George K Grayson, Michael D Meyer

J Med Chem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
William H Bunnelle, Karin R Tietje, Jennifer M Frost, Dan Peters, Jianguo Ji, Michael D Meyer

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
Betty B Yao, Gin Hsieh, Anthony V Daza, Yihong Fan, George K Grayson, Michael D Meyer

J Pharmacol Exp Ther· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of human cannabinoid CB2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins.
John Malysz, Anthony V Daza, Karen Kage, George K Grayson, Betty B Yao, Michael D Meyer

Eur J Pharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions.
Michael W Decker, Murali Gopalakrishnan, Michael D Meyer

Expert Opin Drug Discov· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.
Karin R Tietje, David J Anderson, R Scott Bitner, Eric A Blomme, Paul J Brackemeyer, Michael D Meyer

CNS Neurosci Ther· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
Jennifer M Frost, Michael J Dart, Karin R Tietje, Tiffany R Garrison, George K Grayson, Michael D Meyer

J Med Chem· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
Jianguo Ji, Michael R Schrimpf, Kevin B Sippy, William H Bunnelle, Tao Li, Michael D Meyer

J Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A-366833: a novel nicotinonitrile-substituted 3,6-diazabicyclo[3.2.0]-heptane alpha4beta2 nicotinic acetylcholine receptor selective agonist: Synthesis, analgesic efficacy and tolerability profile in animal models.
Jianguo Ji, William H Bunnelle, David J Anderson, Connie Faltynek, Tino Dyhring, Michael D Meyer

Biochem Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways.
Robert S Bitner, William H Bunnelle, David J Anderson, Clark A Briggs, Jerry Buccafusco, Michael D Meyer

J Neurosci· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
William H Bunnelle, Jerome F Daanen, Keith B Ryther, Michael R Schrimpf, Michael J Dart, Michael D Meyer

J Med Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High- and low-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChRs.
Clark A Briggs, Earl J Gubbins, C Brent Putman, Rama Thimmapaya, Michael D Meyer

J Mol Neurosci· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of 3,8-diazabicyclo[4.2.0]octane ligands, potent nicotinic acetylcholine receptor agonists.
Jennifer M Frost, William H Bunnelle, Karin R Tietje, David J Anderson, Lynne E Rueter, Michael D Meyer

J Med Chem· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
Clark A Briggs, Earl J Gubbins, Michael J Marks, C Brent Putman, Rama Thimmapaya, Michael D Meyer

Mol Pharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of functional neuronal nicotinic receptors in dorsal root ganglion neurons in a rat model of neuropathic pain.
Gilles R Dubé, Kathy L Kohlhaas, Lynne E Rueter, Carol S Surowy, Michael D Meyer

Neurosci Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A-186253, a specific antagonist of the alpha 4 beta 2 nAChRs: its properties and potential to study brain nicotinic acetylcholine receptors.
Valérie Itier, Roland Schönbächler, Eliane Tribollet, Michael Honer, Katja Prinz, Michael D Meyer

Neuropharmacology· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist.
Robert J Altenbach, Albert Khilevich, Teodozyj Kolasa, Jeffrey J Rohde, Pramila A Bhatia, Michael D Meyer

J Med Chem· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral and central sites of action for A-85380 in the spinal nerve ligation model of neuropathic pain.
Lynne E Rueter, Kathy L Kohlhaas, Peter Curzon, Carol S Surowy, Michael D Meyer

Pain· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis